PharmacoScan™ Solution consists of array plates, reagents, instrument consumables, and analysis software. It provides a cost-effective, reproducible, and scalable solution for translational researchers in health care organizations, pharmaceutical companies, and research institutes to study how genetic variations affect prescription drug absorption, distribution, metabolism, and excretion (ADME). By pre-emptively screening samples, the solution provides researchers with insight into pharmacogenomic risk factors in phase I and phase II enzymes, regulatory and/or modifier genes, drug target genes, and phase III/transporter genes.
For Research Use Only. Not for use in diagnostic procedures.